Steven H Bernstein MD
Professor, Medicine, University of Rochester School of Medicine & Dentistry
Join to View Full Profile
601 Elmwood AveBox MedRochester, NY 14642
Phone+1 585-275-0784
Fax+1 585-273-5761
Are you Dr. Bernstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Steven Bernstein, MD is a hematologist in Rochester, New York. He is a Professor at University of Rochester School of Medicine & Dentistry.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1987 - 1991
University of ChicagoResidency, Internal Medicine, 1984 - 1987
New York University School of MedicineClass of 1984
Publications & Presentations
PubMed
- 28 citationsPhase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.Kevin R. Kelly, Jonathan W. Friedberg, Steven I. Park, Kevin T. McDonagh, John Hayslip
Clinical Cancer Research. 2018-12-15 - 13 citationsThe Fast Real-time Assessment of Combination Therapies in Immuno-ONcology (FRACTION) program: innovative, high-throughput clinical screening of immunotherapies.Katy L. Simonsen, Paula M. Fracasso, Steven H. Bernstein, Megan Wind-Rotolo, Manish Gupta
European Journal of Cancer. 2018-11-01 - 94 citationsCirculating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer.Nataly Manjarrez-Orduño, Laurence Menard, Selena Kansal, Paul Fischer, Bijal Kakrecha
Frontiers in Immunology. 2018-08-03
Authored Content
- 'The Fast Real-Time Assessment of Combination Therapies in Immuno-ONcologyOctober 2018
